Related Experiment Video
Updated: Jul 9, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Using the PharmCAT tool for Pharmacogenetic clinical decision support.
Kevin Tippenhauer1, Marwin Philips1, Carlo Largiadèr2
1Bern University of Applied Sciences, Quellgasse 21, 2500 Biel, Switzerland.
PharmCAT aids pharmacogenetic clinical decision support by mapping dosing guidelines to genetic data. This system addresses challenges in integrating genetic variants into clinical workflows for personalized medicine.
Area of Science:
- Pharmacogenetics
- Clinical Informatics
- Genomic Medicine
Background:
- Pharmacogenetics is crucial for personalized medicine, guiding drug selection and dosage based on genetic variations.
- Clinical decision support systems (CDSS) are essential for translating complex genetic information into actionable clinical practice.
- Integrating pharmacogenetic data into electronic health records presents significant technical and logistical challenges.
Purpose of the Study:
- To provide insights into utilizing PharmCAT within a pharmacogenetic clinical decision support pipeline.
- To address the challenges of mapping clinical dosing guidelines to genetic variants.
- To describe the integration of PharmCAT into a clinical information system.
Main Methods:
- General overview of pharmacogenetics principles.
- Detailed description of PharmCAT features and functionalities.
- Explanation of the integration process of PharmCAT into a clinical information system.
Main Results:
- PharmCAT effectively bridges the gap between genetic data and clinical dosing recommendations.
- The integrated system streamlines the process of applying pharmacogenetic insights in patient care.
- Demonstrated a viable pipeline for pharmacogenetic clinical decision support.
Conclusions:
- PharmCAT is a valuable tool for pharmacogenetic clinical decision support.
- Successful integration into clinical information systems is feasible and beneficial.
- Future PharmCAT releases hold promise for advancing pharmacogenetic implementation in healthcare.
More Related Videos
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Drug Discovery: Overview
Biopharmaceutics and Pharmacokinetics: Overview
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...